US 8372835
Pyrrolopyrazines and pyrazolopyrazines useful as inhibitors of protein kinases
granted A61PA61P1/16A61P11/06
Quick answer
US patent 8372835 (Pyrrolopyrazines and pyrazolopyrazines useful as inhibitors of protein kinases) held by Vertex Pharmaceuticals Incorporated expires Mon Feb 07 2033 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Vertex Pharmaceuticals Incorporated
- Grant date
- Tue Feb 12 2013 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Feb 07 2033 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 2
- CPC classes
- A61P, A61P1/16, A61P11/06, A61P15/10, A61P19/00